Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
The International Journal of Psycho-Analysis
|
September 19, 2003
An example from child analysis
Jill M Miller
The Psychoanalytic Study of the Child
|
June 29, 2010
Introduction to Hansi Kennedy's "Children in conflict: Anna Freud and the war nurseries"
Jill M Miller, Carla Neely
Journal of the American Psychoanalytic Association
|
September 3, 2009
Innovation in child psychoanalytic training: an implementation study
Jill M Miller, Robert N Emde
Journal of Immunological Methods
|
March 30, 2010
Rheumatoid factor interference in immunogenicity assays for human monoclonal antibody therapeutics
Suzanna Tatarewicz, Jill M Miller, Steven J Swanson, et al.
Archives of Pathology & Laboratory Medicine
|
January 24, 2019
Combined Pathology-Driven Algorithmic Testing and Integrated Reporting for Bone Marrow Examination
Lauren N Pearson, Jill M Miller, John H Lunde, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
January 17, 2014
Curcumin: a double hit on malignant mesothelioma
Jill M Miller, Joyce K Thompson, Maximilian B MacPherson, et al.
Oncotarget
|
February 9, 2018
Extracellular signal regulated kinase 5 and inflammasome in progression of mesothelioma
Joyce K Thompson, Anurag Shukla, Alan L Leggett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 1, 2013
Extracellular signal-regulated kinase 5: a potential therapeutic target for malignant mesotheliomas
Arti Shukla, Jill M Miller, Christopher Cason, et al.
The American Journal of Pathology
|
August 12, 2014
CREB-induced inflammation is important for malignant mesothelioma growth
Catherine M Westbom, Anurag Shukla, Maximilian B MacPherson, et al.
American Journal of Respiratory Cell and Molecular Biology
|
June 19, 2014
Extracellular signal-regulated kinase 5 and cyclic AMP response element binding protein are novel pathways inhibited by vandetanib (ZD6474) and doxorubicin in mesotheliomas
Mutlay Sayan, Arti Shukla, Maximilian B MacPherson, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
The International Journal of Psycho-Analysis
|
September 19, 2003
An example from child analysis
Jill M Miller
The Psychoanalytic Study of the Child
|
June 29, 2010
Introduction to Hansi Kennedy's "Children in conflict: Anna Freud and the war nurseries"
Jill M Miller, Carla Neely
Journal of the American Psychoanalytic Association
|
September 3, 2009
Innovation in child psychoanalytic training: an implementation study
Jill M Miller, Robert N Emde
Journal of Immunological Methods
|
March 30, 2010
Rheumatoid factor interference in immunogenicity assays for human monoclonal antibody therapeutics
Suzanna Tatarewicz, Jill M Miller, Steven J Swanson, et al.
Archives of Pathology & Laboratory Medicine
|
January 24, 2019
Combined Pathology-Driven Algorithmic Testing and Integrated Reporting for Bone Marrow Examination
Lauren N Pearson, Jill M Miller, John H Lunde, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
January 17, 2014
Curcumin: a double hit on malignant mesothelioma
Jill M Miller, Joyce K Thompson, Maximilian B MacPherson, et al.
Oncotarget
|
February 9, 2018
Extracellular signal regulated kinase 5 and inflammasome in progression of mesothelioma
Joyce K Thompson, Anurag Shukla, Alan L Leggett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 1, 2013
Extracellular signal-regulated kinase 5: a potential therapeutic target for malignant mesotheliomas
Arti Shukla, Jill M Miller, Christopher Cason, et al.
The American Journal of Pathology
|
August 12, 2014
CREB-induced inflammation is important for malignant mesothelioma growth
Catherine M Westbom, Anurag Shukla, Maximilian B MacPherson, et al.
American Journal of Respiratory Cell and Molecular Biology
|
June 19, 2014
Extracellular signal-regulated kinase 5 and cyclic AMP response element binding protein are novel pathways inhibited by vandetanib (ZD6474) and doxorubicin in mesotheliomas
Mutlay Sayan, Arti Shukla, Maximilian B MacPherson, et al.
Page
of 2